InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.26
(
0.00%
)
US TECH 100
19,869.20
(
0.11%
)
Dow Jones
39,336.39
(
-0.10%
)
Brent Oil
85.33
(
-1.36%
)
Bitcoin
56,307.61
(
0.83%
)
Post# of 252518
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

ghmm

Send PM Follow Ignore
Followers 50
Posts 6343
Boards Moderated 0
Alias Born 01/22/2006

ghmm

Re: genisi post# 61385

Monday, 04/14/2008 3:08:04 PM

Monday, April 14, 2008 3:08:04 PM

Post# of 252518
Do you have an updated timeline for Protalix?

I don't think much of Zavesca its sales and label are not very strong, though I don't have your background to comment from a scientific standpoint. I had seen side effects I believe due to its non-selective nature where quite high.

I was looking at some of my old TKT stuff and I don't know if Shire had some setbacks but their time-line for GAGCB is a lot longer then what TKT had talked about.

For the poster who asked the Zacks blurb on Amicus I don't think much of Zacks reports. I saw an early one and will give them credit for having some detail and industry comp's, but basically they pulled a bunch of stuff from their filings and/or presentation. The actual analysis seemed lacking IMO. I am still quite long Amicus and am more curious at what some of the Oral Small molecules do rather then the ERT's. A fund has been really supporting the price the past few months (not there is much volume).

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up